Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$2.85 - $3.73 $176,913 - $231,539
-62,075 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$3.24 - $5.18 $201,123 - $321,548
62,075 New
62,075 $209,000
Q4 2020

Jan 28, 2021

SELL
$4.04 - $5.31 $90,576 - $119,050
-22,420 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$3.64 - $7.76 $81,608 - $173,979
22,420 New
22,420 $94,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.